423 studies found for:    lung tumor | Studies With Results
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Conditions: Lung Cancer;   Small Cell Lung Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Paclitaxel;   Drug: Carboplatin
2 Completed
Has Results
Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Condition: Lung Cancer
Intervention: Device: CyPath
3 Active, not recruiting
Has Results
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
Condition: Lung Cancer
Interventions: Procedure: radiography;   Other: screening questionnaire administration
4 Completed
Has Results
National Lung Screening Trial (NLST) Screening
Condition: Lung Cancer
Interventions: Device: low-dose helical computed tomography;   Device: chest radiography
5 Completed
Has Results
Phase I/II Calcitriol in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Calcitriol
6 Completed
Has Results
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: sunitinib
7 Terminated
Has Results
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pazopanib (GW786034)
8 Terminated
Has Results
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer
Conditions: Malignant Pleural Effusion;   Non Small Cell Lung Cancer
Intervention: Drug: zoledronic acid
9 Completed
Has Results
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: carboxyamidotriazole;   Other: placebo;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
10 Completed
Has Results
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Cancer;   Carcinoma, Non-Small Cell Lung
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
11 Completed
Has Results
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Biological: Cetuximab;   Drug: Docetaxel
12 Completed
Has Results
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Vandetanib
13 Completed
Has Results
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
Conditions: Carcinoma;   Non Small Cell Lung
Interventions: Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®);   Drug: Placebo;   Drug: Docetaxel (Taxotere®);   Drug: Dexamethasone (pre- and post-medication for docetaxel)
14 Terminated
Has Results
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer;   Lung Cancer, Non-Small Cell
Intervention: Drug: GW572016 (lapatinib)
15 Completed
Has Results
A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
Conditions: Non-Small-Cell Lung Carcinoma;   Adenocarcinoma
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: AG-013736 (axitinib)
16 Completed
Has Results
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
Conditions: Lung Cancer;   Precancerous Condition
Interventions: Drug: iloprost;   Other: placebo
17 Active, not recruiting
Has Results
ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Drug: ZD6474 (vandetanib);   Other: Best Supportive Care
18 Completed
Has Results
Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Irinotecan;   Drug: Carboplatin;   Drug: Bevacizumab;   Radiation: Radiation
19 Completed
Has Results
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: RAD001 (everolimus)
20 Completed
Has Results
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: PF-02341066

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years